Previous event: Cancer vaccine launch pad: What do colorectal cancer nurses need to know?
This event is now in the past. You can catch up on previous virtual education events here. You can also find the recording for this event on this page.
About this event:
Held on Thursday 28 November 2024, this session, led by Dr Dan Muller, covered the science behind targeted and personalised cancer vaccines. It provided an overview of the Cancer Vaccine Launch Pad (CVLP), how patients are recruited, what the patient journey looks like and how colorectal clinical teams can support patients within the CVLP and the associated colorectal cancer vaccine trials.
The learning outcomes of this virtual education event were to enable learners to:
- Gain an understanding of what a cancer vaccine is
- Learn what the NHS Cancer Vaccine Launch Pad is
- Understand who is eligible for participation in the NHS Cancer Vaccine Launch Pad and associated colorectal cancer vaccine trial
- Understand the patient journey through the CVLP and associated colorectal cancer vaccine trial
- Understand how colorectal teams can support patients within the CVLP and associated colorectal cancer vaccine trial
Attendees also had the opportunity to participate in a Q&A session with expert speaker Dr Dan Muller, and Max Shen, Programme Manager, NHS National Cancer Programme who be joined Dan during the Q&A session.
Speakers
Dr Dan Muller, Cancer Vaccine Launch Pad Clinical Liaison and Honorary SpR in Medical Oncology, University of Southampton
Dan is in training as a medical oncologist at University Hospital Southampton and is working with the University of Southampton as the Cancer Vaccine Launch Pad’s Clinical Liaison Fellow. Working as a Clinical Liaison, he supports CVLP teams to manage the patient and tissue pathways within the study and ensure as many eligible patients as possible are offered the linked cancer vaccine trial.
Max Shen, Programme Manager, NHS National Cancer Programme, NHS England
Max is a skilled Programme Manager for NHS England with extensive experience in healthcare transformation, particularly in cancer care. Max has successfully led several impactful initiatives within the NHS, focusing on improving patient outcomes and addressing health inequalities. His previous work includes supporting bowel cancer screening initiatives, where he contributed to a significant increase in early cancer detection rates. Currently leading efforts in the NHS Cancer Vaccine Launch Pad, Max plays a key role in driving the future development and expansion of the programme aimed at improving cancer treatment pathways and genomic pathway integration. Max is committed to driving innovation and improving patient outcomes in oncology.